Anne Clem Whitaker Insider Trading $NBS CALADRIUS BIOSCIENCES, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Anne Clem Whitaker.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Anne Clem Whitaker. Anne Clem Whitaker is Director in CALADRIUS BIOSCIENCES, INC. ($NBS) and Director in CREE INC ($CREE) and Director in Valeant Pharmaceuticals International, Inc. ($BVF) and EVP, Company Group Chairman in Valeant Pharmaceuticals International, Inc. ($BVF) and President and CEO in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in Mallinckrodt plc ($MNK).

Anne Clem Whitaker in CALADRIUS BIOSCIENCES, INC.

Trading Symbol: NBS
Industry: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
Position of Anne Clem Whitaker: Director
Holdings: 117,205 shares
Latest Transaction: Jan 12 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Anne Clem Whitaker in CALADRIUS BIOSCIENCES, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BVF, NBS, CREE, SNTA, MNK

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 12 2021NBSCALADRIUS BIOSCIEN ...Whitaker Anne ClemDirectorGrantA0.0037,7350117,20579.5 K to 117.2 K (+47.48 %)
Nov 03 2020NBSCALADRIUS BIOSCIEN ...Whitaker Anne ClemDirectorGrantA1.5179,470120,00079,4700 to 79.5 K

Page:   1